You W, Di A, Zhang L, Zhao G. Effects of wogonin on the growth and metastasis of colon cancer through the Hippo signaling pathway. Bioengineered. 2022;13(2):2586–97.
Article CAS PubMed PubMed Central Google Scholar
Pan X, Li B, Zhang G, Gong Y, Liu R, Chen B, et al. Identification of RORgamma as a favorable biomarker for colon cancer. J Int Med Res. 2021;49(5):3000605211008338.
Article CAS PubMed Google Scholar
Meng F, Cao Y, Su H, Liu T, Tian L, Zhang Y, et al. Newcastle disease virus expressing an angiogenic inhibitor exerts an enhanced therapeutic efficacy in colon cancer model. PLoS ONE. 2022;17(4): e0264896.
Article CAS PubMed PubMed Central Google Scholar
Moghadamyeghaneh Z, Hanna MH, Hwang G, Mills S, Pigazzi A, Stamos MJ, et al. Outcomes of colon resection in patients with metastatic colon cancer. Am J Surg. 2016;212(2):264–71.
Klaver CEL, Kappen TM, Borstlap WAA, Bemelman WA, Tanis PJ. Laparoscopic surgery for T4 colon cancer: a systematic review and meta-analysis. Surg Endosc. 2017;31(12):4902–12.
Article PubMed PubMed Central Google Scholar
O’Malley G, Heijltjes M, Houston AM, Rani S, Ritter T, Egan LJ, et al. Mesenchymal stromal cells (MSCs) and colorectal cancer: a troublesome twosome for the anti-tumour immune response? Oncotarget. 2016;7(37):60752–74.
Article PubMed PubMed Central Google Scholar
Wang S, Miao Z, Yang Q, Wang Y, Zhang J. The dynamic roles of mesenchymal stem cells in colon cancer. Can J Gastroenterol Hepatol. 2018;2018:7628763.
Article PubMed PubMed Central Google Scholar
El-Said MM, Emile SH. Cellular therapy: a promising tool in the future of colorectal surgery. World J Gastroenterol. 2019;25(13):1560–5.
Article PubMed PubMed Central Google Scholar
Yi X, Chen F, Liu F, Peng Q, Li Y, Li S, et al. Comparative separation methods and biological characteristics of human placental and umbilical cord mesenchymal stem cells in serum-free culture conditions. Stem Cell Res Ther. 2020;11(1):183.
Article CAS PubMed PubMed Central Google Scholar
Nombela-Arrieta C, Ritz J, Silberstein LE. The elusive nature and function of mesenchymal stem cells. Nat Rev Mol Cell Biol. 2011;12(2):126–31.
Article CAS PubMed PubMed Central Google Scholar
Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284(5411):143–7.
Article CAS PubMed Google Scholar
Behbod F, Vivanco MD. Side population. Methods Mol Biol. 2015;1293:73–81.
Golebiewska A, Brons NH, Bjerkvig R, Niclou SP. Critical appraisal of the side population assay in stem cell and cancer stem cell research. Cell Stem Cell. 2011;8(2):136–47.
Article CAS PubMed Google Scholar
Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med. 1996;183(4):1797–806.
Article CAS PubMed Google Scholar
Goodell MA, Rosenzweig M, Kim H, Marks DF, DeMaria M, Paradis G, et al. Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat Med. 1997;3(12):1337–45.
Article CAS PubMed Google Scholar
Kato K, Takao T, Kuboyama A, Tanaka Y, Ohgami T, Yamaguchi S, et al. Endometrial cancer side-population cells show prominent migration and have a potential to differentiate into the mesenchymal cell lineage. Am J Pathol. 2010;176(1):381–92.
Article CAS PubMed PubMed Central Google Scholar
Gupta R, Leon F, Rauth S, Batra SK, Ponnusamy MP. A systematic review on the implications of O-linked glycan branching and truncating enzymes on cancer progression and metastasis. Cells. 2020;9(2):446.
Article CAS PubMed PubMed Central Google Scholar
Dong X, Jiang Y, Liu J, Liu Z, Gao T, An G, et al. T-synthase deficiency enhances oncogenic features in human colorectal cancer cells via activation of epithelial-mesenchymal transition. Biomed Res Int. 2018;2018:9532389.
Article PubMed PubMed Central Google Scholar
Iwai T, Inaba N, Naundorf A, Zhang Y, Gotoh M, Iwasaki H, et al. Molecular cloning and characterization of a novel UDP-GlcNAc:GalNAc-peptide beta1,3-N-acetylglucosaminyltransferase (beta 3Gn-T6), an enzyme synthesizing the core 3 structure of O-glycans. J Biol Chem. 2002;277(15):12802–9.
Article CAS PubMed Google Scholar
Hofmann BT, Schluter L, Lange P, Mercanoglu B, Ewald F, Folster A, et al. COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer. Mol Cancer. 2015;14:109.
Article PubMed PubMed Central Google Scholar
Jiang Y, Liu Z, Xu F, Dong X, Cheng Y, Hu Y, et al. Aberrant O-glycosylation contributes to tumorigenesis in human colorectal cancer. J Cell Mol Med. 2018;22(10):4875–85.
Article CAS PubMed PubMed Central Google Scholar
Sun X, Ju T, Cummings RD. Differential expression of Cosmc, T-synthase and mucins in Tn-positive colorectal cancers. BMC Cancer. 2018;18(1):827.
Article PubMed PubMed Central Google Scholar
Itzkowitz SH, Yuan M, Montgomery CK, Kjeldsen T, Takahashi HK, Bigbee WL, Kim YS. Expression of Tn, sialosyl-Tn, and T antigens in human colon cancer. Cancer Res. 1989;49(1):197–204.
Fu C, Zhao H, Wang Y, Cai H, Xiao Y, Zeng Y, et al. Tumor-associated antigens: Tn antigen, sTn antigen, and T antigen. HLA. 2016;88(6):275–86.
Article CAS PubMed Google Scholar
Yu X, Du Z, Sun X, Shi C, Zhang H, Hu T. Aberrant Cosmc genes result in Tn antigen expression in human colorectal carcinoma cell line HT-29. Int J Clin Exp Pathol. 2015;8(3):2590–602.
PubMed PubMed Central Google Scholar
Ju T, Lanneau GS, Gautam T, Wang Y, Xia B, Stowell SR, et al. Human tumor antigens Tn and sialyl Tn arise from mutations in Cosmc. Cancer Res. 2008;68(6):1636–46.
Article CAS PubMed Google Scholar
Zhang A, Zhang J, Li X, Zhang H, Xiong Y, Wang Z, et al. hPMSCs inhibit the expression of PD-1 in CD4(+)IL-10(+) T cells and mitigate liver damage in a GVHD mouse model by regulating the crosstalk between Nrf2 and NF-kappaB signaling pathway. Stem Cell Res Ther. 2021;12(1):368.
Article CAS PubMed PubMed Central Google Scholar
Ding R, Hu X, Hu W, Du Z, Huang P, Wang M, et al. Cosmc transfection decreases malignant behavior of Tn(+) cells and enhances sensitivity to apoptosis when induced by Apo2L/TRAIL via alteration of O-glycan structure. Aging (Albany NY). 2021;13(19):23393–406.
Article CAS PubMed Google Scholar
Dowling CM, Herranz Ors C, Kiely PA. Using real-time impedance-based assays to monitor the effects of fibroblast-derived media on the adhesion, proliferation, migration and invasion of colon cancer cells. Biosci Rep. 2014;34:4.
Ju T, Xia B, Aryal RP, Wang W, Wang Y, Ding X, et al. A novel fluorescent assay for T-synthase activity. Glycobiology. 2011;21(3):352–62.
Article CAS PubMed Google Scholar
Kudelka MR, Antonopoulos A, Wang Y, Duong DM, Song X, Seyfried NT, et al. Cellular O-glycome reporter/amplification to explore O-glycans of living cells. Nat Methods. 2016;13(1):81–6.
Article CAS PubMed Google Scholar
Francois S, Usunier B, Forgue-Lafitte ME, L’Homme B, Benderitter M, Douay L, et al. Mesenchymal stem cell administration attenuates colon cancer progression by modulating the immune component within the colorectal tumor microenvironment. Stem Cells Transl Med. 2019;8(3):285–300.
Article CAS PubMed Google Scholar
Wakao S, Akashi H, Kushida Y, Dezawa M. Muse cells, newly found non-tumorigenic pluripotent stem cells, reside in human mesenchymal tissues. Pathol Int. 2014;64(1):1–9.
Article CAS PubMed Google Scholar
Young W. Future of muse cells. Adv Exp Med Biol. 2018;1103:309–15.
Article CAS PubMed Google Scholar
Liu Z, Liu J, Dong X, Hu X, Jiang Y, Li L, et al. Tn antigen promotes human colorectal cancer metastasis via H-Ras mediated epithelial-mesenchymal transition activation. J Cell Mol Med. 2019;23(3):2083–92.
留言 (0)